ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also ...

Continue reading → ...

In my latest article for Firstlinks, I unpack a fundamental question: why do investors react differently to market fluctuations when they own a listed company versus a private business? If a private ...

In this week’s video insight, I dive into the topic of asset allocation and how to approach balancing risk and return. Using ...

According to the bears, the promised breakthroughs feel eerily like the heady days of the dot.com bubble. Pointing to a market narrative we’ve seen before, AI developments – particularly those ...

As February’s reporting season kicks off, investors are keenly focused on company profits as ASX-listed companies release ...

I joined Sean Aylmer on the Fear and Greed podcast to discuss the latest market turmoil triggered by Chinese artificial intelligence (AI) company, DeepSeek. We explored how DeepSeek’s development of a ...

In this week’s video insight, I discuss the potential shift in the artificial intelligence (AI) and tech landscape following ...